Search

everythinglearnresearchcommunity

for

Search:↓

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

The document is a detailed medical reference on skin and genetic disorders.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

The document concludes that new treatments for hair loss may involve a combination of cosmetics, clinical methods, and genetic approaches.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

The method accurately measures 19 steroid hormones in human blood and urine using a small sample and is suitable for large-scale monitoring.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Zinc can be a helpful secondary treatment for certain skin conditions, but more research is needed to guide its use.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

Low DHEA-S levels might be linked to alopecia areata and could be a potential treatment target.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

The conclusion is that genetic testing is important for diagnosing and treating various genetic hair disorders.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Mutations in the NR3C1 gene cause a rare condition that affects hormone signaling and can lead to various symptoms, with dexamethasone as a treatment option.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Alopecia X in dogs is a cosmetic issue, not a hormonal disorder, and harmful treatments should be avoided.

A woman's severe hair loss was caused by scalp psoriasis, not the initially thought condition, and treatment improved her psoriasis but couldn't restore her lost hair.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.